- Home
- COSM vs CARM Comparison
COSM vs CARM Comparison
Compare COSM & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- CARM
- Stock Information
- Founded
- COSM 2009
- CARM 2016
- Country
- COSM United States
- CARM United States
- Employees
- COSM N/A
- CARM N/A
- Industry
- COSM Other Pharmaceuticals
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- COSM Health Care
- CARM Health Care
- Exchange
- COSM Nasdaq
- CARM Nasdaq
- Market Cap
- COSM 12.3M
- CARM 12.2M
- IPO Year
- COSM 2013
- CARM N/A
- Fundamental
- Price
- COSM $0.93
- CARM $0.31
- Analyst Decision
- COSM
- CARM Hold
- Analyst Count
- COSM 0
- CARM 5
- Target Price
- COSM N/A
- CARM $0.90
- AVG Volume (30 Days)
- COSM 477.5K
- CARM 25.7M
- Earning Date
- COSM 11-13-2025
- CARM 11-06-2025
- Dividend Yield
- COSM N/A
- CARM N/A
- EPS Growth
- COSM N/A
- CARM N/A
- EPS
- COSM N/A
- CARM N/A
- Revenue
- COSM $55,093,442.00
- CARM $10,767,000.00
- Revenue This Year
- COSM $28.14
- CARM N/A
- Revenue Next Year
- COSM N/A
- CARM N/A
- P/E Ratio
- COSM N/A
- CARM N/A
- Revenue Growth
- COSM N/A
- CARM N/A
- 52 Week Low
- COSM $0.28
- CARM $0.14
- 52 Week High
- COSM $1.28
- CARM $1.27
- Technical
- Relative Strength Index (RSI)
- COSM 60.29
- CARM 47.53
- Support Level
- COSM $0.86
- CARM $0.34
- Resistance Level
- COSM $1.07
- CARM $0.39
- Average True Range (ATR)
- COSM 0.10
- CARM 0.06
- MACD
- COSM 0.02
- CARM 0.00
- Stochastic Oscillator
- COSM 73.37
- CARM 29.91
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.